Pavmed inc. (PAVM)
Balance Sheet / Yearly
Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15
Assets
Current assets
Cash

6,219

4,097

6,908

4,190

8,222

9,241

11,137

3,630

1,535

3,111

82

905

585

1,788

3,022

-

767

Prepaid fees to related party

-

-

-

-

-

-

-

-

-

-

-

25

-

-

-

-

-

Cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

236

-

Prepaid fees to related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

25

-

Prepaid expenses and other current assets

328

257

97

129

238

119

86

113

88

103

124

141

155

177

116

65

8

Total current assets

6,547

4,354

7,005

4,319

8,460

9,361

11,224

3,744

1,623

3,214

206

1,072

741

1,966

3,139

326

776

Other assets

692

-

-

-

36

-

-

-

-

-

-

-

-

-

-

-

-

Equipment, net

-

51

54

35

-

36

12

14

16

17

19

21

18

19

13

12

-

Deferred offering costs

-

-

-

-

-

-

-

-

-

0

0

-

111

-

-

441

438

Total assets

7,240

4,405

7,060

4,355

8,496

9,398

11,237

3,758

1,639

3,232

226

1,094

870

1,985

3,152

781

1,214

Liabilities and Equity (Deficit)
Current liabilities
Accounts payable

2,352

1,800

1,427

1,385

1,738

1,638

1,297

767

863

991

1,652

934

949

609

216

359

165

Accrued expenses and other current liabilities

1,386

540

722

386

1,330

738

667

298

706

354

393

212

240

232

187

484

414

Accrued Interest expense

-

-

-

-

-

201

-

194

-

187

-

-

-

-

-

-

-

Senior Secured Convertible Note issued at fair value, face value principal at December 31, 2019 and 2018, respectively

-

4,471

6,790

8,251

-

3,256

2,750

-

-

-

-

-

-

-

-

-

-

Series A Warrants derivative liability

-

-

-

-

-

0

0

0

761

-

-

-

0

-

-

-

-

Series A Warrants

-

-

-

-

-

-

-

-

-

4,731

2,515

3,264

-

-

-

-

-

Series A Convertible Preferred Stock conversion option derivative liability

-

-

-

-

-

0

0

0

212

1,298

714

997

0

-

-

-

-

Total current liabilities

11,878

-

-

-

10,972

5,834

4,715

1,261

2,543

7,563

-

-

1,189

842

403

844

580

Senior Secured Note, net of $3,244,274 unamortized debt discount

-

-

-

-

-

0

0

2,250

1,944

1,582

-

-

0

-

-

-

-

Total liabilities

11,878

6,812

8,939

10,024

10,972

5,834

4,715

3,511

4,488

9,145

5,276

5,408

1,189

-

-

-

-

COMMITMENT AND CONTINGENCIES (NOTE 9)

-

-

-

-

-

0

0

0

-

0

-

0

0

0

0

0

0

Temporary equity value

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

Stockholders' Equity (Deficit)
Preferred Stock, par value $0.001, 20,000,000 shares authorized;

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

Common Stock, par value, $0.001; 100,000,000 shares authorized, 40,478,861 and 27,142,979 shares issued and outstanding as of December 31, 2019 and 2018, respectively

40

36

34

27

27

26

26

17

14

13

13

13

13

13

13

12

12

Additional paid-in capital

47,553

43,251

-

-

32,619

-

-

-

-

-

-

-

-

-

-

-

-

Additional paid-in capital

-

-

40,518

33,025

-

31,756

31,384

19,982

14,012

12,157

7,898

7,644

7,369

7,121

6,798

2,672

2,672

Accumulated deficit

-53,714

-47,402

-44,251

-40,591

-36,992

-30,096

-26,524

-21,459

-17,907

-18,273

-12,961

-11,971

-7,701

-5,991

-4,062

-2,747

-2,050

Total PAVmed Inc. stockholders' equity (deficit)

-3,823

-1,886

-1,536

-5,442

-2,314

3,654

6,593

247

-2,848

-5,913

-5,049

-4,314

-319

1,143

2,749

-62

633

Noncontrolling interest in majority-owned subsidiaries

-814

-520

-342

-225

-161

-90

-72

-

-

-

-

-

-

-

-

-

-

Total deficit

-4,638

-2,406

-1,879

-5,668

-2,476

3,563

6,521

-

-2,848

-

-

-

-

-

-

-

-

Total Liabilities and Equity (Deficit)

7,240

4,405

7,060

4,355

8,496

9,398

11,237

3,758

1,639

3,232

226

1,094

870

1,985

3,152

781

1,214

Senior Secured Convertible Note Issued on December 27, 2018 [Member]
Senior Secured Convertible Note issued at fair value, face value principal at December 31, 2019 and 2018, respectively

1,700

-

-

-

7,903

-

-

-

-

-

-

-

-

-

-

-

-

Senior Secured Convertible Note Issued on November 4, 2019 [Member]
Senior Secured Convertible Note issued at fair value, face value principal at December 31, 2019 and 2018, respectively

6,439

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Series B Convertible Preferred Stock [Member]
Preferred Stock, par value $0.001, 20,000,000 shares authorized;

2,296

2,228

2,161

2,096

2,031

-

-

-

-

-

-

-

-

-

-

-

-

Total deficit

2,296

2,228

2,161

2,096

2,031

-

-

-

-

-

-

-

-

-

-

-

-

Series A-1 Convertible Preferred Stock [Member]
Convertible Preferred Stock

-

-

-

-

-

-

-

-

1,032

-

-

-

-

-

-

-

-

Total stockholders' deficit

-

-

-

-

-

-

-

-

1,032

-

-

-

-

-

-

-

-